OA03.08 Activity of Ensartinib after Second Generation Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors (TKI)
Year: 2017
Type: conference-abstract
Source: Journal of Thoracic Oncology
Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Dana-Farber Cancer Institute, Stanford University, The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Moffitt Cancer Center, Xcovery (United States), City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2766023027